Androgenetic Alopecia

October 2013 in “ Der Hautarzt ”

Ulrike Blume‐Peytavi, Annika Vogt

androgenetic alopecia AGA topical medications systemic medications cosmetic products nutricosmetics hair transplantation aesthetic-corrective methods S1 guidelines S3 guidelines

TLDR Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Androgenetic alopecia (AGA) was identified as a common cause of hair loss, significantly impacting the quality of life across different ages and genders. The study emphasized the importance of a thorough and standardized diagnostic approach for AGA in developing effective treatment plans. Treatment options included topical and systemic medications, cosmetic products, nutricosmetics, hair transplantation, and aesthetic-corrective methods. The decision on the best treatment was to be made collaboratively by the physician and patient, considering expected outcomes, practicality, and compliance. The study also highlighted the need for interdisciplinary evaluation and psychological support to manage the emotional impact of AGA. The S1 and S3 guidelines provided essential tools for evidence-based management of AGA, aiming to enhance patient satisfaction and compliance through a professional and sensitive approach.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

26 / 26 results

research Investigation of Six Novel Susceptibility Loci for Male Androgenetic Alopecia in Women With Female Pattern Hair Loss

25 citations , July 2013 in “Journal of Dermatological Science”

Six new hair loss factors in men not linked to female hair loss.

research Evidence for a Polygenic Contribution to Androgenetic Alopecia

26 citations , May 2013 in “British Journal of Dermatology”

Hair loss risk is influenced by multiple genes.

research Androgenetic Alopecia: Identification Of Four Genetic Risk Loci And Evidence For The Contribution Of WNT Signaling To Its Etiology

74 citations , January 2013 in “Journal of Investigative Dermatology”

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

research Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men

198 citations , October 2011 in “Journal der Deutschen Dermatologischen Gesellschaft”

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

research A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

81 citations , August 2011 in “Journal of The American Academy of Dermatology”

Latanoprost 0.1% may effectively treat hair loss.

A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women

research A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women

100 citations , June 2011 in “Journal of The American Academy of Dermatology”

5% minoxidil foam once daily works as well as 2% minoxidil solution twice daily for female hair growth and is more convenient.

research Finasteride-Induced Secondary Infertility Associated with Sperm DNA Damage

36 citations , February 2011 in “Fertility and Sterility”

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

research Current Standards in the Diagnostics and Therapy of Hair Diseases - Hair Consultation

10 citations , February 2011 in “Journal der Deutschen Dermatologischen Gesellschaft”

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

research Finasteride-Associated Male Infertility

38 citations , December 2010 in “Fertility and Sterility”

Finasteride may cause male infertility, stopping it can help.

research Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia

152 citations , October 2010 in “Archives of Dermatology”

Finasteride helps hair growth but may cause sexual side effects.

research S1 Guideline for Diagnostic Evaluation in Androgenetic Alopecia in Men, Women, and Adolescents

151 citations , August 2010 in “British Journal of Dermatology”

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

research Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?

12 citations , January 2010 in “PubMed”

No definitive link between finasteride and male breast cancer, but further research is needed.

research Diagnosis of Hair Disorders

73 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

research Susceptibility Variants for Male-Pattern Baldness on Chromosome 20p11

140 citations , October 2008 in “Nature Genetics”

research Female Pattern Hair Loss

16 citations , June 2008 in “Springer eBooks”

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

research Prostanoid Receptors in Anagen Human Hair Follicles

39 citations , November 2007 in “Experimental dermatology”

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations , August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

research Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia

195 citations , June 2005 in “American Journal of Human Genetics”

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

research Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia

162 citations , August 2004 in “Journal of Investigative Dermatology”

Hair loss causes stress and affects mental health; treatment and support needed.

research Finasteride-Associated Male Infertility

34 citations , January 2004 in “Revista do Hospital das Clínicas”

Finasteride may worsen infertility in men with existing issues, but stopping it can improve sperm health.

research Genetic Basis of Male Pattern Baldness

191 citations , December 2003 in “Journal of Investigative Dermatology”

research Effects of Minoxidil 2% vs. Cyproterone Acetate Treatment on Female Androgenetic Alopecia: A Controlled, 12-Month Randomized Trial

149 citations , June 2002 in “British Journal of Dermatology”

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

research The Prevalence and Types of Androgenetic Alopecia in Korean Men and Women

157 citations , July 2001 in “British Journal of Dermatology”

AGA more common in men, Koreans have lower rates and unique patterns.

research Hypertrichosis Induced by Latanoprost

39 citations , April 2001 in “Journal of The American Academy of Dermatology”

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

research Psychological Effects of Androgenetic Alopecia on Women: Comparisons with Balding Men and Female Control Subjects

222 citations , October 1993 in “Journal of The American Academy of Dermatology”

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

research Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex

666 citations , September 1977 in “British Journal of Dermatology”

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Similar Research

5 / 1000+ results

research Interventions for Female Pattern Hair Loss

21 citations , May 2016 in “The Cochrane library”

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

research Microneedling and Its Use in Hair Loss Disorders: A Systematic Review

2 citations , December 2021 in “Dermatology and therapy”

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

research Nanomaterials in Hair Care and Treatment

5 citations , February 2022 in “Acta Biomaterialia”

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

research Characteristics of Androgenetic Alopecia in Asian Populations

51 citations , January 2012 in “Annals of Dermatology”

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

research Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics

17 citations , November 2021 in “Journal of Cosmetic Dermatology”

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.